Alligator Bioscience AB Reports Major Share Capital Expansion
“Alligator Bioscience AB has boosted its total outstanding shares and votes to 534,516,986 as of January 30, 2026, following a directed issuance tied to its recent rights offering. This marks a substantial increase from the prior count of 497,346,986, driven by compensation to guarantors, enhancing the company’s financial flexibility amid its immuno-oncology pipeline advancements.” Share … Read more